Exp Mol Med.  2004 Apr;36(2):165-171.

Inactivation patterns of p16/INK4A in oral squamous cell carcinomas

Affiliations
  • 1Department of Dentistry, School of Medicine, Ajou University, Suwon 442-749, Korea. arcady@ajou.ac.kr
  • 2Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University, Seoul 110-749, Korea.
  • 3Department of Oral and Maxillofacial Pathology, College of Dentistry, Seoul National University, Seoul 110-749, Korea.

Abstract

The p16/INK4A is one of the major target genes in carcinogenesis and its inactivation has frequently been reported in other types of tumors. The purpose of this study is to evaluate inactivation patterns of p16/INK4A in oral squamous cell carcinoma. Six different oral cancer cell lines, SCC-4, SCC-9, SCC-15, SCC-25, KB, and SNUDH- 379 were examined for inactivation of p16/INK4A genes. In the analysis of p16/INK4A gene inactivation, PCR amplification, direct sequencing, and methylation-specific PCR methods were adopted for evaluation of homozygous deletion, point mutation, and promoter hypermethylation, respectively. Homozygous deletion was detected in SCC-25 and SCC-9. SCC-15 showed hypermethylated promoter region within p16/INK4A gene. It is suggestive in the present study that inactivation patterns of p16/INK4A were mainly homozygous deletion, promoter methylation rather than point mutation in oral squamous cancer cell lines, so treatment modalities of oral squamous cell carcinoma should be focused on these types of inactivation.

Keyword

homozygous deletion; oral squamous cell carcinoma; p16/INK4A; promoter methylation

MeSH Terms

Carcinoma, Squamous Cell/*genetics
Cell Line, Tumor
DNA Methylation
*Gene Silencing
Homozygote
Humans
Mouth Neoplasms/*genetics
Point Mutation
Promoter Regions (Genetics)/genetics
Protein p16/*genetics
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr